Betz Halloran | Academic Influence

Betz Halloran's AcademicInfluence.com Rankings

Betz Halloran

Mathematics

#4638

World Rank

#6567

Historical Rank

#1580

USA Rank

Statistics

#363

World Rank

#430

Historical Rank

#120

USA Rank

mathematics Degrees

Download Badge

Mathematics

Betz Halloran's Degrees

PhD Biostatistics University of Washington
Masters Biostatistics University of Washington
Bachelors Mathematics University of Washington

Similar Degrees You Can Earn

Best Online Bachelor's in Math 2025

Why Is Betz Halloran Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Mary Elizabeth Halloran is an American biostatistician who works as a professor of biostatistics, professor of epidemiology, and adjunct professor of applied mathematics at the University of Washington.

(See a Problem?)

Betz Halloran's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak (2020) (2808)
Containing Pandemic Influenza at the Source (2005) (1220)
Containing pandemic influenza with antiviral agents. (2004) (746)
Antibody-dependent enhancement of severe dengue disease in humans (2017) (681)
Bootstrap confidence levels for phylogenetic trees. (1996) (659)
Toward Causal Inference With Interference (2008) (641)
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study (2020) (575)
The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus (2009) (575)
Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19 (2020) (532)
A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys (1996) (531)
Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China (2020) (496)
The effect of travel restrictions on the spread of the 2019 novel coronavirus (2019-nCoV) outbreak (2020) (426)
Cost-effectiveness of a routine varicella vaccination program for US children. (1994) (388)
Bootstrap confidence levels for phylogenetic trees. (1996) (375)
Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics (2009) (363)
Household Transmission of SARS-CoV-2 (2020) (355)
Containing Bioterrorist Smallpox (2002) (353)
Assessing the International Spreading Risk Associated with the 2014 West African Ebola Outbreak (2014) (341)
FluTE, a Publicly Available Stochastic Influenza Epidemic Simulation Model (2010) (340)
Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate (2020) (338)
Aggregated mobility data could help fight COVID-19 (2020) (331)
Zika virus evolution and spread in the Americas (2017) (313)
Population-wide benefits of routine vaccination of children against influenza. (2005) (312)
Study designs for evaluating different efficacy and effectiveness aspects of vaccines. (1997) (308)
Design and Analysis of Vaccine Studies (2009) (300)
Direct and indirect effects in vaccine efficacy and effectiveness. (1991) (267)
Causal Inference in Infectious Diseases (1995) (263)
Spread of Zika virus in the Americas (2017) (252)
Spatiotemporal spread of the 2014 outbreak of Ebola virus disease in Liberia and the effectiveness of non-pharmaceutical interventions: a computational modelling analysis. (2015) (233)
Study designs for dependent happenings. (1991) (229)
Strategy for distribution of influenza vaccine to high-risk groups and children. (2005) (219)
Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys (1997) (202)
Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. (2005) (201)
Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. (1994) (200)
Statistical models in epidemiology, the environment, and clinical trials (2000) (192)
Interpretation and estimation of vaccine efficacy under heterogeneity. (1992) (187)
Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study (2021) (163)
Design and interpretation of vaccine field studies. (1999) (162)
Strategies for Pandemic and Seasonal Influenza Vaccination of Schoolchildren in the United States (2009) (158)
Vaccination strategies for epidemic cholera in Haiti with implications for the developing world (2011) (155)
Assessing the impact of travel restrictions on international spread of the 2014 West African Ebola epidemic. (2014) (155)
Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. (2006) (154)
Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model. (2009) (143)
Inferring high-resolution human mixing patterns for disease modeling (2020) (142)
Persistent infection of macaques with simian-human immunodeficiency viruses (1995) (139)
Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic (2020) (132)
School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States. (2010) (132)
The dengue vaccine pipeline: Implications for the future of dengue control. (2015) (125)
Zika virus infection enhances future risk of severe dengue disease (2020) (123)
Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. (1995) (116)
Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. (2000) (110)
A Frailty Mixture Model for Estimating Vaccine Efficacy (1996) (110)
Measures of the effects of vaccination in a randomly mixing population. (1991) (110)
The Envelope Glycoprotein Ectodomains Determine the Efficiency of CD4+ T Lymphocyte Depletion in Simian– Human Immunodeficiency Virus–Infected Macaques (1998) (107)
Containing a large bioterrorist smallpox attack: a computer simulation approach. (2007) (105)
Opinion: Mathematical models: A key tool for outbreak response (2014) (103)
Estimability and interpretation of vaccine efficacy using frailty mixing models. (1996) (99)
Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand. (2002) (98)
Controlling Dengue with Vaccines in Thailand (2012) (96)
Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. (2004) (92)
T cell receptor V beta repertoire in an acute infection of rhesus monkeys with simian immunodeficiency viruses and a chimeric simian- human immunodeficiency virus (1995) (92)
Estimating Influenza Vaccine Efficacy From Challenge and Community-based Study Data (2008) (88)
Malaria: living with drug resistance. (1993) (87)
Changes in Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Responsible for the Pathogenicity of a Multiply Passaged Simian-Human Immunodeficiency Virus (SHIV-HXBc2) (1999) (86)
Factors Associated With Household Transmission of SARS-CoV-2 (2021) (86)
The Global Transmission and Control of Influenza (2011) (84)
Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. (2003) (84)
Detecting Human-to-Human Transmission of Avian Influenza A (H5N1) (2007) (83)
Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone (2016) (81)
Design and evaluation of prophylactic interventions using infectious disease incidence data from close contact groups (2006) (81)
Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. (2003) (78)
Empirical Bayes methods for stabilizing incidence rates before mapping. (1994) (77)
Community interventions and the epidemic prevention potential. (2002) (77)
Causal Vaccine Effects on Binary Postinfection Outcomes (2006) (75)
Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. (2003) (73)
Mycobacterium bovis bacille Calmette-Guérin enhances pathogenicity of simian immunodeficiency virus infection and accelerates progression to AIDS in macaques: a role of persistent T cell activation in AIDS pathogenesis. (1999) (73)
Community Studies for Vaccinating Schoolchildren Against Influenza (2006) (69)
Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. (1996) (69)
Assessing effects of cholera vaccination in the presence of interference (2014) (66)
Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. (1998) (64)
Modeling malaria vaccines. II: Population effects of stage-specific malaria vaccines dependent on natural boosting. (1989) (63)
Estimation of vaccine efficacy in the presence of waning: application to cholera vaccines. (1998) (62)
Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. (2016) (62)
Simulations for designing and interpreting intervention trials in infectious diseases (2017) (61)
Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination (1998) (60)
Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. (2020) (59)
Optimal Vaccine Allocation for the Early Mitigation of Pandemic Influenza (2013) (59)
Modeling malaria vaccines. I: New uses for old ideas. (1989) (57)
Containing Ebola at the Source with Ring Vaccination (2016) (57)
Transition to endemicity: Understanding COVID-19 (2021) (56)
Interference and Sensitivity Analysis. (2014) (56)
Dependent Happenings: a Recent Methodological Review (2016) (55)
Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. (2007) (54)
The behaviour of common measures of association used to assess a vaccination programme under complex disease transmission patterns--a computer simulation study of malaria vaccines. (1990) (54)
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them. (2020) (54)
Counting Process Models for Infectious Disease Data: Distinguishing Exposure to Infection from Susceptibility (1996) (53)
Exposure efficacy and change in contact rates in evaluating prophylactic HIV vaccines in the field. (1994) (52)
Evolving epidemiology of novel coronavirus diseases 2019 and possible interruption of local transmission outside Hubei Province in China: a descriptive and modeling study (2020) (51)
Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis (2022) (51)
Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects. (2012) (50)
Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial (2017) (50)
The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016 (2016) (50)
Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico (2018) (50)
Estimating Within-School Contact Networks to Understand Influenza Transmission (2011) (49)
Characterization of Simian-Human Immunodeficiency Virus Envelope Glycoprotein Epitopes Recognized by Neutralizing Antibodies from Infected Monkeys (1998) (49)
Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis. (1996) (47)
Epidemiologic effects of varicella vaccination. (1996) (47)
Ebola: mobility data. (2014) (46)
Household Transmission of Vibrio cholerae in Bangladesh (2014) (44)
Projected Impact of Dengue Vaccination in Yucatán, Mexico (2016) (43)
Efficacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and Reports (2021) (43)
HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection (2012) (43)
Performance of rapid influenza H1N1 diagnostic tests: a meta‐analysis (2011) (42)
Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status (2022) (42)
Epidemiologic effects of vaccines with complex direct effects in an age-structured population. (1994) (42)
Using validation sets for outcomes and exposure to infection in vaccine field studies. (2001) (41)
Estimating Vaccine Efficacy From Secondary Attack Rates (2003) (41)
Measuring vaccine efficacy from epidemics of acute infectious agents. (1993) (40)
Persistent Arthralgia Associated with Chikungunya Virus Outbreak, US Virgin Islands, December 2014–February 2016 (2017) (39)
Molecular Infectious Disease Epidemiology: Survival Analysis and Algorithms Linking Phylogenies to Transmission Trees (2015) (39)
Experimental Study of the Fermi Surfaces of Niobium and Tantalum (1970) (39)
Infectious disease and the Unesco basic education initiative. (1989) (39)
Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave (2021) (38)
Public health. Community studies for vaccinating schoolchildren against influenza. (2006) (38)
Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design (2017) (38)
Estimating the transmission probability of human immunodeficiency virus in injecting drug users in Thailand (2001) (36)
Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis (2016) (36)
On estimation of vaccine efficacy using validation samples with selection bias. (2006) (35)
Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacy. (1998) (35)
Forecasting the effectiveness of indoor residual spraying for reducing dengue burden (2018) (35)
Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas (2020) (35)
Estimating the establishment of local transmission and the cryptic phase of the COVID-19 pandemic in the USA (2020) (34)
Design of vaccine efficacy trials during public health emergencies (2019) (34)
A case-control study of the effectiveness of BCG vaccine for preventing leprosy in Yangon, Myanmar. (1997) (34)
Planning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United States. (2011) (34)
Causal Inference for Vaccine Effects on Infectiousness (2012) (33)
Estimation of vaccine efficacy in outbreaks of acute infectious diseases. (1991) (33)
Modeling transmission dynamics of stage-specific malaria vaccines. (1992) (32)
Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials (2020) (30)
Preliminary assessment of the International Spreading Risk Associated with the 2019 novel Coronavirus (2019-nCoV) outbreak in Wuhan City (2020) (30)
Efficiency of Estimating Vaccine Efficacy for Susceptibility and Infectiousness: Randomization by Individual Versus Household (1999) (30)
Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus (1995) (29)
A family study of lymphedema of the leg in a lymphatic filariasis-endemic area. (2004) (29)
Model‐based estimation of vaccine effects from community vaccine trials (2002) (28)
ESTIMATING WITHIN-HOUSEHOLD CONTACT NETWORKS FROM EGOCENTRIC DATA. (2011) (28)
A Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines. (1999) (27)
The First Reported Outbreak of Chikungunya in the U.S. Virgin Islands, 2014–2015 (2016) (27)
Methods for Identifying Neisseria meningitidis Carriers: A Multi-Center Study in the African Meningitis Belt (2013) (27)
School-Located Influenza Vaccination Reduces Community Risk for Influenza and Influenza-Like Illness Emergency Care Visits (2014) (27)
A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections. (2009) (26)
Empirical bayes estimators for spatially correlated incidence rates (1994) (26)
Accounting for Variability in Sample Size Estimation with Applications to Nonadherence and Estimation of Variance and Effect Size (2007) (26)
Estimation of vaccine efficacy from epidemics of acute infectious agents under vaccine-related heterogeneity. (1993) (26)
Experimental study of the Fermi surface of vanadium (1974) (26)
The Effects of Vector Movement and Distribution in a Mathematical Model of Dengue Transmission (2013) (26)
Comparative Effectiveness of Different Strategies of Oral Cholera Vaccination in Bangladesh: A Modeling Study (2014) (26)
On the distribution of vaccine protection under heterogeneous response. (1993) (25)
In vivo effects of a bacterial superantigen on macaque TCR repertoires. (1998) (25)
The Effect of Age on Transmission of 2009 Pandemic Influenza A (H1N1) in a Camp and Associated Households (2011) (25)
Seven challenges for model-driven data collection in experimental and observational studies. (2015) (24)
Randomization and baseline transmission in vaccine field trials (2006) (23)
PREDICTIVE MODELING OF CHOLERA OUTBREAKS IN BANGLADESH. (2014) (23)
Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine (2018) (23)
An acutely lethal simian immunodeficiency virus stimulates expansion of V beta 7- and V beta 14-expressing T lymphocytes. (1994) (22)
Comparison of Two Smoothing Methods for Exploring Waning Vaccine Effects (1999) (22)
Containing Pandemic Influenza at the Source : Supporting Online Material (2005) (22)
Projected spread of Zika virus in the Americas (2016) (22)
Achieving coordinated national immunity and cholera elimination in Haiti through vaccination: a modelling study (2019) (21)
One versus two doses: What is the best use of vaccine in an influenza pandemic? (2015) (21)
Overview of Vaccine Field Studies: Types of Effects and Designs (2006) (20)
Assessment of families for excess risk of lymphedema of the leg in a lymphatic filariasis-endemic area. (2004) (20)
Modeling Competing Infectious Pathogens From a Bayesian Perspective: Application to Influenza Studies With Incomplete Laboratory Results (2010) (20)
Estimating the cost of illness and burden of disease associated with the 2014–2015 chikungunya outbreak in the U.S. Virgin Islands (2019) (19)
Effects of infection history on dengue virus infection and pathogenicity (2019) (19)
Estimating Strain‐Specific and Overall Efficacy of Polyvalent Vaccines Against Recurrent Pathogens From a Cross‐Sectional Study (2013) (19)
Inferring high-resolution human mixing patterns for disease modeling (2020) (19)
On individual and population effectiveness of vaccination. (1995) (19)
The Minicommunity Design to Assess Indirect Effects of Vaccination (2012) (19)
Designing effective control of dengue with combined interventions (2020) (19)
Estimating the effect of cooperative versus uncooperative strategies of COVID-19 vaccine allocation: a modeling study (2020) (19)
Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014. (2015) (19)
Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up (2018) (18)
The effect of disease prior to an outbreak on estimates of vaccine efficacy following the outbreak. (1995) (18)
Bayesian estimation of vaccine efficacy (2004) (18)
Invited commentary: Challenges of using contact data to understand acute respiratory disease transmission. (2006) (17)
Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study (2017) (17)
Case Definition and Design Sensitivity (2013) (16)
Preliminary results of models to predict areas in the Americas with increased likelihood of Zika virus transmission in 2017 (2017) (16)
Semiparametric Methods for Multiple Exposure Mismeasurement and a Bivariate Outcome in HIV Vaccine Trials (1999) (16)
Estimating vaccine efficacy using auxiliary outcome data and a small validation sample (2004) (16)
Effectiveness of seasonal influenza vaccination of children in Senegal during a year of vaccine mismatch: a cluster-randomized trial. (2019) (15)
Ebola and beyond (2015) (15)
Emerging, evolving, and established infectious diseases and interventions (2014) (15)
A Resampling-Based Test to Detect Person-To-Person Transmission of Infectious Disease. (2007) (14)
A Hybrid EM and Monte Carlo EM Algorithm and Its Application to Analysis of Transmission of Infectious Diseases (2012) (14)
Malaria vaccines: lessons from field trials. (1994) (14)
AIDS: modeling epidemic control (1995) (13)
Binomial and Stochastic Transmission Models (2010) (13)
Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico (2018) (13)
The TIRS trial: protocol for a cluster randomized controlled trial assessing the efficacy of preventive targeted indoor residual spraying to reduce Aedes-borne viral illnesses in Merida, Mexico (2020) (12)
Semi-parametric models for mismeasured exposure information in vaccine trials. (1998) (12)
Recent developments in theories of pathogenesis of AIDS. (1996) (12)
A STATISTICAL ANALYSIS OF MEMORY CD8 T CELL DIFFERENTIATION : AN APPLICATION OF A HIERARCHICAL STATE SPACE MODEL TO A SHORT TIME COURSE MICROARRAY EXPERIMENT (2007) (11)
DISCUSSION: VACCINE EFFECT ON SUSCEPTIBILITY (1996) (11)
Estimation of Vaccine Efficacy in Non‐Randomly Mixing Populations (1995) (11)
ON THE USE OF STATE-SPACE MODELS FOR THE EVALUATION OF HEALTH INTERVENTIONS (1995) (11)
A data-augmentation method for infectious disease incidence data from close contact groups (2007) (11)
Genomic epidemiology supports multiple introductions and cryptic transmission of Zika virus in Colombia (2018) (11)
Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in China (2018) (10)
Secondary Attack Rate (2005) (10)
Population biology, evolution, and immunology of vaccination and vaccination programs. (1998) (10)
Impact of Rotavirus Vaccine Introduction in Children Less Than 2 Years of Age Presenting for Medical Care With Diarrhea in Rural Matlab, Bangladesh (2019) (9)
Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015–2016 ZIKV epidemic (2018) (9)
Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial (2018) (9)
Estimating population effects of vaccination using large, routinely collected data (2018) (9)
A Bayesian Framework for Estimating Vaccine Efficacy per Infectious Contact. (2009) (9)
Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term (2021) (9)
T Cell Receptor V ~ Repertoire in an Acute Infection of Rhesus Monkeys with Simian Immunodeficiency Viruses and a Chimeric Simian-Human Immunodeficiency Virus (2003) (9)
Challenges of evaluating and modelling vaccination in emerging infectious diseases (2021) (8)
Identifying areas with elevated disease incidence rates using empirical Bayes estimators (2010) (8)
Surrogates of Protection (2010) (8)
Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States (2021) (8)
Evaluating the Effectiveness of Vaccines Using a Regression Discontinuity Design (2019) (8)
Estimating heterogeneous transmission with multiple infectives using MCMC methods (2004) (7)
Disseminated Effects in Agent Based Models: A Potential Outcomes Framework and Application to Inform Pre-Exposure Prophylaxis Coverage Levels for HIV Prevention. (2020) (7)
Infectious Disease Modeling Contributions to the American Journal of Epidemiology (2005) (7)
Aggregating data from COVID-19 trials (2020) (7)
Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease (2018) (7)
Real-Time Assessment of the International Spreading Risk Associated with the 2014 West African Ebola Outbreak (2016) (7)
Comparing biomarkers as trial level general surrogates (2015) (7)
Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential (2020) (7)
Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks (2018) (7)
Dengue seroprevalence in a cohort of schoolchildren and their siblings in Yucatan, Mexico (2015-2016) (2018) (7)
DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR. (2018) (6)
Incorporating real-time influenza detection into the test-negative design for estimating influenza vaccine effectiveness: The real-time test-negative design (rtTND). (2020) (6)
Testing for contributions of mitochondrial DNA mutations to complex diseases (1998) (6)
Considerations for the design of vaccine efficacy trials during public health emergencies (2018) (6)
Temporal Confounding in the Test Negative Design. (2020) (6)
Estimates of inactivated influenza vaccine effectiveness among children in Senegal: results from two consecutive cluster-randomized controlled trials in 2010 and 2011. (2020) (6)
Invited commentary: Evaluating vaccination programs using genetic sequence data. (2009) (5)
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats (2022) (5)
An Assessment of Household and Individual-Level Mosquito Prevention Methods during the Chikungunya Virus Outbreak in the United States Virgin Islands, 2014–2015 (2018) (5)
Networks of face-to-face social contacts in Niakhar, Senegal (2019) (5)
Assessing Indirect, Total, and Overall Effects (2010) (5)
Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better? (2019) (5)
Genome sequencing reveals Zika virus diversity and spread in the Americas (2017) (5)
Infectious diseases of humans: dynamics and control (pbk edn): by Roy M. Anderson and Robert M. May Oxford University Press, 1992. £22.50 pbk (viii + 757 pages) ISBN 0 19 854040 X (1993) (5)
Association of Diphtheria-Tetanus–Acellular Pertussis Vaccine Timeliness and Number of Doses With Age-Specific Pertussis Risk in Infants and Young Children (2021) (5)
Modeling the impacts of clinical influenza testing on influenza vaccine effectiveness estimates. (2021) (5)
Overview of Vaccine Effects and Study Designs (2010) (5)
The contribution of neighbours to an individual's risk of typhoid outcome (2015) (5)
Protecting the herd with vaccination. (2022) (4)
Causal Inference in the Study of Infectious Disease (2017) (4)
A pathway EM‐algorithm for estimating vaccine efficacy with a non‐monotone validation set (2014) (4)
IN4 ECONOMIC EVALUATION OF INFLUENZA PANDEMIC MITIGATION STRATEGIES IN THE US USING A STOCHASTIC MICROSIMULATION INFLUENZA MODEL (2007) (4)
On influenza and school closings: time for prospective studies. (2009) (4)
Inverse probability weighted estimators of vaccine effects accommodating partial interference and censoring (2019) (4)
Safety of cold-adapted live influenza vaccine. (2004) (4)
Estimating the risk of sustained community transmission of COVID-19 outside Mainland China (2020) (4)
Successes and failures of the live-attenuated influenza vaccine, can we do better? (2018) (4)
New fermi surface results in AuGa2 (1971) (4)
Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies. (2016) (4)
Modes of Action and Time-Varying VE S (2010) (4)
Comparing bounds for vaccine effects on infectiousness. (2012) (4)
Statistical issues in phase III human immunodeficiency virus vaccine trial design (1998) (4)
Estimands and inference in cluster‐randomized vaccine trials (2019) (4)
[Direct and indirect effects of vaccines: an annotation on the estimation of the vaccine efficacy from outbreaks caused by acute infection agents such as measles]. (1990) (3)
The case for a typhoid vaccine probe study and overview of design elements. (2015) (3)
Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions (2020) (3)
Apparatus for Adiabatic Rotation of a Sample in a Magnetic Field at Liquid Helium Temperatures (1968) (3)
Cost-effectiveness of live-attenuated influenza vaccination among school-age children. (2020) (3)
Design and Analysis of Infectious Disease Studies (2009) (3)
Mycobacterium tuberculosis: just desserts for an ungrateful guest. (1994) (3)
Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemic (2021) (3)
Evolutionary consequences of delaying intervention for monkeypox (2022) (3)
A Conversation about COVID-19 with Biostatisticians and Epidemiologists (2020) (2)
Bayesian Data Analysis.@@@Bayes and Empirical Bayes Methods for Data Analysis. (1997) (2)
Optimizing and evaluating biomarker combinations as trial‐level general surrogates (2018) (2)
Analysis of Vaccine Studies and Causal Inference (2019) (2)
Comment on AIDS and COVID‐19: A tale of two pandemics and the role of statisticians (2021) (2)
Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington. (2021) (2)
COMMUNICABLE DISEASES AND DATA ANALYSIS (2011) (2)
Persistence, drugs and rock'n'roll. (1992) (2)
Reply to Aguiar and Stollenwerk. (2018) (2)
Salmonella enteritidis infections in France and the United States: causes vs causal models. (1993) (2)
Modeling AIDS vaccines: the cellular level. (1992) (2)
Age-specific prevalence estimates and risk factors for asymptomatic Neisseria meningitidis carriage in Bamako, Mali (2012) (2)
Designing a Study of Correlates of Risk for Ebola Vaccination (2018) (2)
Introduction and Examples (2010) (1)
Stabilization of the antigenicity of coxsackie B procapsids by disoxaril. (1993) (1)
Estimating Causal Effects of HIV Prevention Interventions with Interference in Network-based Studies among People Who Inject Drugs (2021) (1)
Using simulated infectious disease outbreaks to guide the design of individually randomized vaccine trials (2021) (1)
Estimating the impact of COVID-19 vaccine allocation inequities: a modeling study (2022) (1)
Household-Based Studies (2009) (1)
Reply to Vani et al.: Tuberculosis models and complexity (2009) (1)
A mathematical model for the control of dengue using vaccines (2012) (1)
Effects of infection history on dengue virus infection and pathogenicity (2019) (1)
Algorithms linking phylogenetic and transmission trees for molecular infectious disease epidemiology (2015) (1)
Routine Childhood Varicella Vaccination-Reply (1994) (1)
Improving adolescent human papillomavirus (HPV) immunization uptake in school-based health centers through awareness campaigns. (2021) (1)
A Bayesian approach to estimating causal vaccine effects on binary post‐infection outcomes (2016) (1)
Evaluating Protective Effects of Vaccination (2009) (1)
Practice of Epidemiology Planning for the Control of Pandemic Influenza A ( H 1 N 1 ) in Los Angeles County and the United States (2011) (1)
Discussion on “Estimating vaccine efficacy over time after a randomized study is unblinded” by Anastasios A. Tsiatis and Marie Davidian (2021) (1)
Material Comparing Bounds for Vaccine Effects on Infectiousness (2012) (1)
The global transmission and control of influenza : Supporting Text 1 (2011) (1)
Covariate-constrained randomization with cluster selection and substitution. (2023) (0)
Activation in AIDS Pathogenesis Macaques : A Role of Persistent T cell Accelerates Progression to AIDS in Immunodeficiency Virus Infection and Enhances Pathogenicity of Simian Bacille Calmette-Guérin Mycobacterium bovis (1999) (0)
Quantifying the risk of local Zika virus transmission in the continental US during the 2015-2016 ZIKV epidemic (2018) (0)
Supplementary Material: Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic (2020) (0)
Symposium on population biology, evolution, and control of infectious diseases. Introduction. (1998) (0)
Evaluating Spillover Effects in Network-Based Studies In the Presence of Missing Outcomes (2023) (0)
Evaluating the Mediating Role of Recall of Intervention Knowledge in the Relationship Between a Peer-Driven Intervention and HIV Risk Behaviors Among People Who Inject Drugs (2022) (0)
Validity of university students’ self-reported vaccination status after a meningococcal B outbreak (2020) (0)
On the use of nonlinear state-space models for vaccine evaluation (1993) (0)
Reply to Skowronski and De Serres. (2019) (0)
Online Supporting Text S 2 : Parameter selection for the model (2012) (0)
The de Haas - Van Alphen Effect in Antimony. (1964) (0)
Immunology and Early Phase Trials (2010) (0)
Models for Infectious Human Diseases: Feasibility of prophylactic HIV-vaccine trials: some statistical issues (1996) (0)
Design of Vaccine Trials during Outbreaks with and without a Delayed Vaccination Comparator (2016) (0)
Spillover benefit of pre-exposure prophylaxis for HIV prevention: evaluating the importance of effect modification using an agent-based model (2022) (0)
Methods for Assessing Spillover in Network-Based Studies of HIV/AIDS Prevention among People Who Use Drugs (2023) (0)
Bioterrorism: the statistical issues (2004) (0)
Supplementary Materials for Comparing Biomarkers as Trial Level General Surrogates (2015) (0)
The Design and Analysis of Vaccine Trials for Zika and Dengue (2017) (0)
Interference and Sensitivity Analysis this share you. Your story (2015) (0)
An acutely lethal simian immunodeficiency virus stimulates expansion of Vp 7-and Vp 14-expressing T lymphocytes ( superantgen / T-cedf receptor VP repertolre / AIDS / SIVsmmPBJ 14 ) (0)
Macaque TCR Repertoires In Vivo Effects of a Bacterial Superantigen on (2013) (0)
Safety of cold-adapted live influenza vaccine. Authors' reply (2004) (0)
ANALYSIS OF MEMORY CD 8 T CELL DIFFERENTIATION 443 done in the context of a large research effort to understand immune memory in (2007) (0)
Evaluation and comparison of predictive individual-level general surrogates. (2018) (0)
Analysis of Households in Communities (2010) (0)
Histo-Blood Group Antigen Null Phenotypes Associated With a Decreased Risk of Clinical Rotavirus Vaccine Failure Among Children <2 Years of Age Participating in the Vaccine Impact on Diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia (2023) (0)
Estimating Vaccine Efficacy from Secondary Attack Rates Author ( s ) : (2008) (0)
PIN19: ROUTINE CHILDHOOD VACCINATION AGAINST INFLUENZA:AN ANALYSIS OF CLINICAL AND ECONOMIC BENEFITS (2003) (0)
HLA targeting efficiency correlates with human T-cell responses magnitude and with mortality from Influenza-A infection (105.30) (2012) (0)
Using social contact data to improve the overall effect estimate of a cluster‐randomized influenza vaccination program in Senegal (2020) (0)
Epidemiology Temporal Confounding in the Test-Negative Design (2020) (0)
R0 and Deterministic Models (2010) (0)
Online Supporting Text S 1 : Dengue transmission model description (2012) (0)
Vaccine Effects on Post-Infection Outcomes (2010) (0)
Finding influential subjects in a network using a causal framework. (2023) (0)
Reply to Lindsey, Höschler and de Silva. (2020) (0)
Propensity Score in the Face of Interference: Discussion of Rosenbaum and Rubin (1983) (2023) (0)
Using Case Description Information to Reduce Sensitivity to Bias for the Attributable Fraction Among the Exposed (2022) (0)
The authors reply: Simpler common-sense methods may be preferable to “empirical bayes” (1995) (0)
Randomization and Baseline Transmission (2010) (0)
Further Evaluation of Protective Effects (2010) (0)
From Immunogenicity to Vaccine Efficacy: Insights from Statistical and Causal Models (2008) (0)
Estimation of Vaccine Efficacy for Prophylactic HIV Vaccines (2001) (0)
Estimating population-level effects of the acellular pertussis vaccine using routinely collected immunization data. (2021) (0)
Analysis of Independent Households (2010) (0)
Comment on Laber et al. (2018) (0)
Fit this SIR model to the data to learn something about the longevity of the immunity to SARS-CoV-2. They also present data on the percentage of seroconverted individuals (2022) (0)
Projections of Zika spread in the Continental US (2016) (0)

This paper list is powered by the following services:

Other Resources About Betz Halloran

en.wikipedia.org

What Schools Are Affiliated With Betz Halloran?

Betz Halloran is affiliated with the following schools: